ArticleBMC cancer2019

Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas.

Hanna Engqvist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.